Medication adherence and complementary therapy usage in inflammatory bowel disease patients during the coronavirus disease 2019 pandemic

BACKGROUND AND AIM: Medication nonadherence is common in patients with inflammatory bowel disease (IBD) and has been associated with worse outcomes. The coronavirus disease 2019 (COVID‐19) pandemic led to significant consumer and medical concern regarding the possible risks of immunosuppressive medi...

Descripción completa

Detalles Bibliográficos
Autores principales: Barnes, Alex, Andrews, Jane, Spizzo, Paul, Mountifield, Réme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114986/
https://www.ncbi.nlm.nih.gov/pubmed/34013059
http://dx.doi.org/10.1002/jgh3.12537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8114986/
https://www.ncbi.nlm.nih.gov/pubmed/34013059
http://dx.doi.org/10.1002/jgh3.12537

Ejemplares similares